Archived Activities
Home NIV Therapy for COPD
Home NIV Therapy for COPD Resource Center – Activity One
COPD2Home NIV Therapy for COPD Resource Center – Activity Two
COPD3Home NIV Therapy for COPD Resource Center – Activity Three
COPD4Home NIV Therapy for COPD Resource Center – Activity Four
COPD5Novel Ventilatory Modes of NIV to Treat Chronic Respiratory Failure in COPD and Obesity – Activity Five
COPD6Home NIV Therapy for COPD Resource Center – Activity Six
Servo Ventilation Therapy for Sleep Disordered Breathing
COPD Advanced Patient Management: Post-Acute Care
Optimizing Discharge Planning Following Hospitalizations in Patients with COPD
APM 21) Dyspnea in COPD 2) Ambulatory Home Oxygen – What is the Evidence and Who does it Help?
APM 3Airway Secretion and Clearance in COPD
APM 4Noninvasive ventilation to treat chronic respiratory failure in COPD patients
APM 5Telemedicine and Telehealth Care in COPD
APM 6Pulmonary Rehabilitation and its Components in the Management of the Patient with Advanced COPD
Improving Admission-Free Survival in Persistent Hypercapnic COPD
Gold COPD
GOLD COPD Care Continuum Resource Center
1. BackgroundBackground and Purpose of GOLD
2. Definition and OverviewDefinition and Overview of COPD
3. Diagnosis and AssessmentDiagnosis and Assessment of COPD
4. Therapeutic OptionsOverview of Therapeutic Options
5. Stable COPDManagement of Stable COPD
6. ExacerbationsDefinition of and Management of Exacerbations
7. ComorbiditiesComorbidities in COPD
8. AsthmaAsthma COPD Overlap
9. Implementing StrategyImplementing GOLD Strategy in Your Clinical Setting
10. Future Needs and SummaryThe Future of COPD and GOLD
Anticoagulation
Advances in Anticoagulation
Lupus AnticoagulantLupus Anticoagulant (LA): Choosing the Right Testing Strategy for Your Laboratory
NOACsOral Anticoagulation and the Novel Oral Anticoagulants (NOACs): Where Are We at Midterm?
Oral AnticoagulationOral Anticoagulation
Post-WarfarinPost-Warfarin
Bladder Cancer
Do Variants in Non-muscle-invasive Bladder Cancer (NMIBC) Matter?
3. LotanUnderstanding Biomarker Performance for Bladder Cancer Surveillance
4. KamatUnderstanding the Spectrum of Tumors after BCG Failure
4. WitjesHow to Treat Bladder Cancer When BCG is Unavailable
5. StenzlWhat to Do Now That My Patient's Tumor Has Been Molecularly Characterized
6. ShariatManagement of T1 High-grade Bladder Cancer
7. GrossmanRole of Neoadjuvant Chemotherapy in Bladder Cancer
8. CattoOptimal Surveillance for Follow-up of NMIBC
